Arş. Gör. Bülent BARAN

Yayın Ağı

Makaleler 38

1. Extra intestinal manifestations may increase the risk of synchronous and metachronous development of other extraintestinal manifestations in patients with Crohn’s disease

Ozkahraman A., Kayar Y., Dertli R., Konur S., Kılıc G., Baran B., et al.

Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded)

2. Is the Y90-radioembolization treatment effective on the intermediate-advanced stage of hepatocellular carcinoma and what is the albumin-bilirubin score’s prediction factor for survival?

Evirgen S., ÇAVUŞ B., Gokturk S., Iliaz R., ÖZKAN Z. G., Baran B., et al.

Hepatology Forum , cilt.4, sa.3, ss.103-107, 2023 (Scopus)

3. Mucocutaneous Manifestations and Associated Factors in Patients with Crohn's Disease

Kayar Y., Dertli R., Konür Ş., Ağın M., Al Kafee A., Baran B., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.33, sa.11, ss.945-954, 2022 (SCI-Expanded)

4. Cyclosporine Therapy as a Rescue Treatment in Steroid Refractory Acute Severe Ulcerative Colitis: A Real Life Data From a Tertiary Center

Evirgen S., Iliaz R., Akyuz F., Cavus B., Gokturk S., Ormeci A., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.33, sa.6, ss.463-469, 2022 (SCI-Expanded)

5. Septic arthritis: a presentation of Crohn's disease

Ozpolat H. T., Baran B., Akyuz F.

LANCET GASTROENTEROLOGY & HEPATOLOGY , cilt.7, sa.2, ss.196, 2022 (SCI-Expanded)

6. The development of extraintestinal manifestation and related risk factors in Crohn's patients

Kayar Y., Dertli R., Konur S., Agin M., Baran B., Ormeci A., et al.

IRISH JOURNAL OF MEDICAL SCIENCE , cilt.190, sa.2, ss.597-604, 2021 (SCI-Expanded)

7. Skin lesions indicate cause of acute gastrointestinal bleeding: neurofibromatosis type 1

Ozpolat H. T., Baran B., Akyuz F.

LANCET , cilt.396, sa.10255, 2020 (SCI-Expanded)

8. Risk factors associated with progression to intestinal complications of Crohn disease

Kayar Y., Baran B., Ormeci A., Akyuz F., Demir K., Besisik F., et al.

CHINESE MEDICAL JOURNAL , cilt.132, sa.20, ss.2423-2429, 2019 (SCI-Expanded)

9. Cryptogenic liver cirrhosis and hepatitis E virus (HEV): Are they related?

Akyuz F., Cavus B., Pinarbasi B., Bozaci M., Baran B., Akyuz U., et al.

Annals of Hepatology , cilt.18, sa.4, ss.585-589, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

10. Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes?

İLIAZ R., AKYÜZ F., Yeğen G., ÖRMECI A., GÖKTÜRK S., AKYÜZ Ü., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.29, sa.4, ss.384-391, 2018 (SCI-Expanded)

11. Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers

Iliaz R., Ozpolat T., Baran B., Demir K., Kaymakoglu S., Besisik F., et al.

European Journal of Gastroenterology and Hepatology , cilt.30, sa.7, ss.786-791, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

12. Current state and clinical outcome in Turkish patients with hepatocellular carcinoma

Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Evirgen S., et al.

WORLD JOURNAL OF HEPATOLOGY , cilt.10, sa.1, ss.51-61, 2018 (ESCI)

13. Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts A retrospective cohort study

Soyer O. M., Baran B., Ormeci A., Sahin D., Gokturk S., Evirgen S., et al.

MEDICINE , cilt.96, sa.1, 2017 (SCI-Expanded)

14. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels

Ormeci A., Aydın Y., Sumnu A., Baran B., Soyer O. M., Pinarbasi B., et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , cilt.52, ss.68-73, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

15. Retention during capsule endoscopy: Is it a real problem in routine practice?

Ormeci A., Akyuz F., Baran B., Gokturk S., Ormeci T., Pinarbasi B., et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.44, sa.4, ss.968-975, 2016 (SCI-Expanded)

16. Comparison of the efficacy of 12 months and longer courses of interferon therapy for the treatment of chronic delta hepatitis: a retrospective cohort study

Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., Onel D., et al.

POSTGRADUATE MEDICINE , cilt.128, sa.4, ss.432-438, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

17. Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism?

ORMECI A., Emrence Z., BARAN B., SOYER O., GOKTURK S., EVIRGEN S., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.20, sa.9, ss.1795-1797, 2016 (SCI-Expanded)

18. What is the impact of capsule endoscopy in the long term period?

Ormeci A., Akyuz F., Baran B., Gokturk S., Ormeci T., Pinarbasi B., et al.

WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY , cilt.8, sa.7, ss.344-348, 2016 (ESCI)

19. Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection

Ormeci A., Akyuz F., BARAN B., SOYER O., GÖKTÜRK S., ONEL M., et al.

European Review for Medical and Pharmacological Sciences , cilt.20, sa.5, ss.858-865, 2016 (SCI-Expanded)

20. In Situ Adenocarcinoma of the Ileum in Crohn’s Disease: A Possible Link with Latent CMV Infection?

KAYMAKOĞLU S., Baran B., Goksel S., Ince U., BAKIR B., Bugra D., et al.

Journal of Gastrointestinal Cancer , cilt.45, sa.1, ss.252-256, 2014 (Scopus)

21. Non-alcoholic fatty liver disease: What has changed in the treatment since the beginning?

Baran B., Akyuz F.

WORLD JOURNAL OF GASTROENTEROLOGY , cilt.20, sa.39, ss.14219-14229, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

22. Effects of Polymorphisms in Interferon lambda 3 (Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection

Yilmaz E., Baran B., Soyer O. M., Onel M., Onel D., Ormeci A., et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.12, sa.10, ss.1753-1758, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

23. A Case of Late-Onset Angioedema Associated With Clozapine and Redevelopment of Angioedema With Olanzapine

Tatar Z. B., Oflaz S., Baran B.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , cilt.34, sa.4, ss.523-525, 2014 (SCI-Expanded)

24. Acute hepatitis B due to immune-escape mutations in a naturally immune patient

Kaymakoglu S., Baran B., Onel D., Badur S., Atamer T., Akyuz F.

ACTA GASTRO-ENTEROLOGICA BELGICA , sa.2, ss.262-265, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

25. Ultra-Deep Pyrosequencing of Precore/Core Promoter Mutations in Patients with Genotype D Chronic Hepatitis B

Akyüz F., ÇİFTÇİ S., KESKİN F., Çakıris A., Pinarbasi B., BARAN B., et al.

Journal of Gastroenterology and Hepatology Research , cilt.3, sa.4, ss.1030-1034, 2014 (Scopus) Sürdürülebilir Kalkınma

26. Efficacy of tenofovir in adefovir-experienced patients compared with treatment-naive patients with chronic hepatitis B

KESKİN O., Ormeci A., Baran B., Kabacam G., Tuzun A., Karatayli E., et al.

ANTIVIRAL THERAPY , cilt.19, sa.6, ss.543-550, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

27. Nodular Lymphoid Hyperplasia of Duodenum Caused by Giardiasis

Baran B., Gulluoglu M., Akyuz F.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.11, sa.10, 2013 (SCI-Expanded)

28. Rosai-Dorfman disease with diffuse gastrointestinal involvement

Baran B., Karaca C., Soyer O. M., Yonal I., Isiklar A. D., Cakmak R., et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY , cilt.25, sa.7, ss.869-874, 2013 (SCI-Expanded)

29. Angiographic embolization of large duodenal varix in a cirrhotic patient

Baran B., Soyer O. M., Poyanli A., Karaca C.

DIGESTIVE AND LIVER DISEASE , cilt.45, sa.5, ss.437, 2013 (SCI-Expanded)

30. Effect of Genotypic Differences in CYP2C19 and on Cure Rates for Helicobacter pylori Infection by Triple Therapy With Different Proton Pump Inhibitors

Demir K., ORMECI A., Emrence Z., Gokturk S., Baran B., SOYER O. M., et al.

GASTROENTEROLOGY , cilt.144, sa.5, 2013 (SCI-Expanded)

31. Terry's nail: an overlooked physical finding in cirrhosis

Baran B., Soyer O. M., Karaca C.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL , cilt.12, sa.1, ss.109, 2013 (SCI-Expanded)

32. Efficacy of pegylated interferon-alpha treatment for 24 months in chronic delta hepatitis and predictors of response

Karaca C., Soyer O. M., Baran B., Ormeci A., Gokturk S., Aydin E., et al.

ANTIVIRAL THERAPY , cilt.18, sa.4, ss.561-566, 2013 (SCI-Expanded)

33. Unusual location of polypectomy with an ultra-slim gastroscope: Biliary polyp (with video)

Karaca C., Baran B., Soyer O. M.

DIGESTIVE ENDOSCOPY , cilt.24, sa.6, ss.477, 2012 (SCI-Expanded)

34. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder

TÜKEL R., GÜRVIT H., OZATA B., OZTÜRK N., ERTEKIN B., ERTEKIN E., et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS , cilt.159B, sa.7, ss.850-858, 2012 (SCI-Expanded)

35. Questions About Calculating the Effects of Albumin Therapy for Spontaneous Bacterial Peritonitis

Baran B., Akyuz F., Khishigsuren B.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.10, sa.8, ss.950, 2012 (SCI-Expanded)

36. Does Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique

UYANIKOĞLU A., Akyuz F., Ermis F., Arici S., Bas G., ÇAKIRCA M., et al.

JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY , cilt.18, sa.2, ss.187-193, 2012 (SCI-Expanded)

37. Acute pancreatitis associated with H1N1 influenza during 2009 pandemic: A case report

Baran B., Karaca C., Soyer O. M., Lacin S., Demir K., Besisik F., et al.

Clinics and Research in Hepatology and Gastroenterology , cilt.36, sa.4, 2012 (SCI-Expanded)

38. Comments on Histologic Predictors of Fibrosis Progression in Posttransplant Hepatitis C Recurrence

Baran B., Karaca C., Akyuz F.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY , cilt.8, sa.8, ss.735, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 12

1. Chronic Renal Failure after Liver Transplantation in Long Term: Prevalence and Risk Factors.

Gokturk S., Baran B., Ormeci A., Soyer O., Evirgen S., Ozden I., et al.

Joint International Congress of ILTS, ELITA and LICAGE, London, Kanada, 4 - 07 Haziran 2014, cilt.20, (Özet Bildiri)

2. Baseline alfa-fetoprotein level is a strong predictor of vascular invasion and survival in patients with hepatocellular carcinoma

Ekinci O., Baran B., Ormeci A., Soyer O. M., Gokturk S., Poyanli A., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)

3. The antiviral efficacy of entecavir is not influenced by prior treatment with nucleos(t)ide analogues in patients with chronic hepatitis B

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri)

4. Tenofovir disoproxil fumarate has a substantial efficacy against adefovir and multi-drug resistant strains of hepatitis B virus

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Virological Supression Does not Prevent the Development of Hepatocellular Carsinoma in Cirrhotic Patients with Genotype D Hepatitis B Infection

Gokturk S., Basar R., Ucar A. R., Basgoze B. H., Altinkaynak M., Buyukballi P., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri) Sürdürülebilir Kalkınma

6. Risk factors for significant liver fibrosis in genotype D HBeAg-negative chronic hepatitis B infection with persistently normal ALT and high serum HBVDNA levels

Ormeci A., Akyuz F., Baran B., Soyer O. M., Gokturk S., Karaca C., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, (Özet Bildiri) Sürdürülebilir Kalkınma

7. Safety of Tenofovir in Renal Transplanted and Hemodialysis Patients with Chronic Hepatitis B

Akyuz F., Gokturk S., Baran B., Ormeci A., Soyer O. M., Evirgen S., et al.

64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri) Sürdürülebilir Kalkınma

8. Number connection test-A and inhibitor control test are not efficient for diagnosis of minimal hepatic encephalopathy in cirrhotic patients

Baran B., Ozcan E., Oztop N., Cakmak R., Soyer O. M., Ormeci A., et al.

63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, Amerika Birleşik Devletleri, 9 - 13 Kasım 2012, cilt.56, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

316

H-İndeks (WoS)

Atıf (Scopus)

335

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler